CoChat

Comprehensive analysis of 42 psilocybin-producing fungal strains reveals metabolite diversity and species-specific clusters

Open access

The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.

Abstract

Psilocybin-producing fungi have garnered attention due to accumulating evidence regarding the therapeutic potential of their principal component psilocybin. This diverse group of fungi harbors a wealth of less-studied metabolites, however, thus far most research has addressed them as a cohesive group. By optimizing an approach for extraction and analysis, we examined the metabolomes of 42 distinct fungi strains and show that the breadth and diversity of metabolites within and between 9 species. We integrated and validated the reproducible and reliable extraction of fruiting bodies followed by chromatographic separation, quantification and identification of their known and yet to be identified secondary metabolites. The optimal extraction of fruiting bodies for high yield of indole alkaloids was achieved using a 1:20 tissue:solvent ratio, 25:75 H2O:MeOH (pH = 9), for 1.5 h, followed by the quantification of 8 tryptophan-derived indolamines by HPLC–DAD and the identification of putative metabolite hydroxypsilocybin by HPLC–MS/MS. The metabolomic analysis revealed the diversity of metabolites within and between species. Finally, we developed and present a method that mimics the in vivo process of dephosphorylation that occurs upon ingestion for in vitro setups. Overall, our study summarizes a standardized approach for both in vitro and in vivo studies involving psilocybin-producing fungi, showcasing the unique metabolome of each strain and the rich diversity of these fungi, encompassing promising pharmaceutical potential.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-025-97710-z

Cites

79 of 79 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Establishment of optimal extraction methodologies. (A) Phenotypical differences in fruiting bodies of Psilocybe cubensis BG, Panaeolus cyanescens Vietnam and Psilocybe tampanensis TampG when fresh (top) and after drying (bottom). Dried fruiting bodies are ground and extracted, the solvent is removed and the sample is completely dried by lyophilization (right). To capture images, the fungi were positioned on the same black background and photographed individually. (B–D) Fungi were assessed by HPLC–DAD for the concentration (%w/w) of the major indolamine metabolites psilocybin and psilocin, and the minor metabolite baeocystin following extraction with different (B) time intervals, (C) tissue to solvent ratio, and (D) H2O:MeOH solvent ratio at 100:0, 50:50, 25:75 and 0:100, respectively. (E) Extracted tissue of the three fungi was re-extracted two additional times and the relative levels of psilocybin, psilocin and baeocystin were assessed with HPLC–DAD. (F) The fruiting bodies of the three fungi were extracted for 1.5 h at 1:20 (tissue:solvent) with 25:75 (H2O:MeOH) solvent where the H2O (pH 6.8) was buffered with ammonium acetate to pH = 9. Then, the relative levels of psilocybin, psilocin and baeocystin were assessed with HPLC–DAD. Results are presented as mean (n = 3) ± %RSD.
Fig. 1 Establishment of optimal extraction methodologies. (A) Phenotypical differences in fruiting bodies of Psilocybe cubensis BG, Panaeolus cyanescens Vietnam and Psilocybe tampanensis TampG when fresh (top) and after drying (bottom). Dried fruiting bodies are ground and extracted, the solvent is removed and the sample is completely dried by lyophilization (right). To capture images, the fungi were positioned on the same black background and photographed individually. (B–D) Fungi were assessed by HPLC–DAD for the concentration (%w/w) of the major indolamine metabolites psilocybin and psilocin, and the minor metabolite baeocystin following extraction with different (B) time intervals, (C) tissue to solvent ratio, and (D) H2O:MeOH solvent ratio at 100:0, 50:50, 25:75 and 0:100, respectively. (E) Extracted tissue of the three fungi was re-extracted two additional times and the relative levels of psilocybin, psilocin and baeocystin were assessed with HPLC–DAD. (F) The fruiting bodies of the three fungi were extracted for 1.5 h at 1:20 (tissue:solvent) with 25:75 (H2O:MeOH) solvent where the H2O (pH 6.8) was buffered with ammonium acetate to pH = 9. Then, the relative levels of psilocybin, psilocin and baeocystin were assessed with HPLC–DAD. Results are presented as mean (n = 3) ± %RSD.CC BY-NC-ND · PubMed Central
Fig. 2 Separation, quantification and identification of known and unknown indolamine-type metabolites. (A) Structural formulas and chemical transformations of known tryptophan-derived indolamine metabolites. (B) HPLC–DAD chromatograms of Psilocybe cubensis BG, Panaeolus cyanescens Vietnam and Psilocybe tampanensis TampG and a mix of 8 standards (S1–S8): norbaeocystin, baeocystin, aeruginascin, psilocybin, norpsilocin, psilocin, tryptophan and tryptamine; respectively. Axes represent the abundance (mAU) and the RT (min) at a wavelength of 275 nm. (C–D) HPLC–MS/MS chromatogram showing the (C) standards of norbaeocystin (S1), psilocybin (S4) and psilocin (S6); and (D) Putative hydroxypsilocybin found in Psilocybe cubensis Golden Teacher. Full MS scan was performed in the range of 50–1,000 m/z. (E–F) MS/MS fragmentation spectra (50–325 m/z range) of (E) Psilocybin (S4) and putative hydroxypsilocybin.
Fig. 2 Separation, quantification and identification of known and unknown indolamine-type metabolites. (A) Structural formulas and chemical transformations of known tryptophan-derived indolamine metabolites. (B) HPLC–DAD chromatograms of Psilocybe cubensis BG, Panaeolus cyanescens Vietnam and Psilocybe tampanensis TampG and a mix of 8 standards (S1–S8): norbaeocystin, baeocystin, aeruginascin, psilocybin, norpsilocin, psilocin, tryptophan and tryptamine; respectively. Axes represent the abundance (mAU) and the RT (min) at a wavelength of 275 nm. (C–D) HPLC–MS/MS chromatogram showing the (C) standards of norbaeocystin (S1), psilocybin (S4) and psilocin (S6); and (D) Putative hydroxypsilocybin found in Psilocybe cubensis Golden Teacher. Full MS scan was performed in the range of 50–1,000 m/z. (E–F) MS/MS fragmentation spectra (50–325 m/z range) of (E) Psilocybin (S4) and putative hydroxypsilocybin.CC BY-NC-ND · PubMed Central
Fig. 3 Principle Component Analysis (PCA) of 42 psilocybin-producing fungi strains. The fruiting bodies of 42 fungi were extracted for 1.5 h at 1:20 (tissue:solvent) with 25:75 (H2O:MeOH) solvent. Then, extracts were subjected to HPLC–MS/MS analyses (n = 3) and the metabolomic data are presented in the PCA score plot. Colors represent fungi specie according to morphological identification; shapes represent fungi specie according to ITS classification. X-axis represents the first principal component and y-axis represents an uncorrelated second highest variance component. Psilocybe cubensis BG, Panaeolus cyanescens Vietnam and Psilocybe tampanensis TampG are indicated.
Fig. 3 Principle Component Analysis (PCA) of 42 psilocybin-producing fungi strains. The fruiting bodies of 42 fungi were extracted for 1.5 h at 1:20 (tissue:solvent) with 25:75 (H2O:MeOH) solvent. Then, extracts were subjected to HPLC–MS/MS analyses (n = 3) and the metabolomic data are presented in the PCA score plot. Colors represent fungi specie according to morphological identification; shapes represent fungi specie according to ITS classification. X-axis represents the first principal component and y-axis represents an uncorrelated second highest variance component. Psilocybe cubensis BG, Panaeolus cyanescens Vietnam and Psilocybe tampanensis TampG are indicated.CC BY-NC-ND · PubMed Central
Fig. 4 In vitro dephosphorylation of fungal extracts. (A) Dephosphorylation of psilocybin to psilocin by AP at 37 °C releases the phosphate group (blue) from the oxygen in position C-4 of the indolamine structure, resulting in its hydrolysis. (B) Enzyme kinetics graph displaying Michaelis–Menten curve for the conversion of psilocybin to psilocin (n = 3). (C) An extract of Psilocybe cubensis BG was diluted in AP buffer and added 1 µl of AP (20 U) working at a conversion rate of 1200 ng/ml psilocybin per 1 min. The reaction was halted by adding equal volume EtOH to the reaction mix after an amount of minutes corresponding to the quantified psilocybin concentration. Samples from the original extract (green) and the dephosphorylated one (blue) were quantified according to our HPLC–DAD method at 263 nm. The peaks of psilocybin and psilocin are indicated.
Fig. 4 In vitro dephosphorylation of fungal extracts. (A) Dephosphorylation of psilocybin to psilocin by AP at 37 °C releases the phosphate group (blue) from the oxygen in position C-4 of the indolamine structure, resulting in its hydrolysis. (B) Enzyme kinetics graph displaying Michaelis–Menten curve for the conversion of psilocybin to psilocin (n = 3). (C) An extract of Psilocybe cubensis BG was diluted in AP buffer and added 1 µl of AP (20 U) working at a conversion rate of 1200 ng/ml psilocybin per 1 min. The reaction was halted by adding equal volume EtOH to the reaction mix after an amount of minutes corresponding to the quantified psilocybin concentration. Samples from the original extract (green) and the dephosphorylated one (blue) were quantified according to our HPLC–DAD method at 263 nm. The peaks of psilocybin and psilocin are indicated.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 79 references

Research works printed but not linked: 3

  1. Guzmán, G., Allen, J. W. & Gartz, J. A Worldwide geographical distribution of the Neurotropic fungi, an analysis and discussion. Africa 14(1939), 1–107 (1997).
  2. Stijve, T., Klan, J. & Kuyper, T. Occurrence of psilocybin and baeocystin in the genus Inocybe (Fr.) Fr. Persoonia Mol. Phylogeny Evol. Fungi 12(4), 469–473 (1985).
  3. Gartz, J. Occurrence of psilocybin, psilocin and baeocystin in Gymnopilus purpuratus. Persoonia Mol. Phylogeny Evol. Fungi 14(1), 19–22 (1989).

Cited by

See all 8

Metadata

Authors
Cohen, J., Sulimani, L., Procaccia, S., Lerenthal, Y., Milay, L., Taran, I., Shapira, A., & Meiri, D.
Affiliations
Technion – Israel Institute of Technology (IL)
Corresponding author
Meiri, David
Venue
Scientific Reports
Published
2025-04-22
Volume
15
Issue
1
Pages
13822-13822
ISSN
2045-2322 (ISSN-L)
OpenAlex
W4409693197
Cited by
8
References
79
Citations by year
2026: 7 · 2025: 1
FWCI
9.41
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
PsygaBio (2031221)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
  • Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
Keywords
metabolome, secondary metabolites, indole alkaloids, psilocybin, dephosphorylation, metabolite diversity
MeSH terms
Chromatography, High Pressure Liquid, Fungi, Hallucinogens, Psilocybin, Species Specificity, Tandem Mass Spectrometry, Metabolomics, Metabolome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comprehensive analysis of 42 psilocybin-producing fungal strains reveals metabolite diversity and species-specific clusters. https://app.cochat.ai/papers/10.1038/s41598-025-97710-z
The paper
Cohen, J., Sulimani, L., Procaccia, S., Lerenthal, Y., Milay, L., Taran, I., Shapira, A., & Meiri, D. (2025). Comprehensive analysis of 42 psilocybin-producing fungal strains reveals metabolite diversity and species-specific clusters. Scientific Reports. https://doi.org/10.1038/s41598-025-97710-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.